Keyphrases
25(OH)D3
17%
25-hydroxyvitamin D3
19%
Atopic Dermatitis
38%
CDKN2A mutation
17%
Complete Response
31%
Cutaneous Leishmaniasis
64%
Cyclin-dependent Kinase 4 (CDK4)
14%
Immunoglobulin E
14%
Israel
73%
Israeli
25%
Jewish
29%
Leishmania Braziliensis
19%
Leishmania Major
23%
Leishmania Tropica
29%
Liposomal Amphotericin B
31%
Malignant Melanoma
29%
Medical Center
14%
Melanocytic Nevus
19%
Melanoma
38%
Melanoma Patients
18%
Melanoma Risk
24%
Metastatic Melanoma
21%
Mycosis Fungoides
63%
Narrowband Ultraviolet B Phototherapy
14%
Narrowband UVB
56%
Neural Systems
19%
Nevus
19%
Odds Ratio
17%
Outdoor Workers
24%
Pancreatic Cancer
16%
Pediatric Psoriasis
19%
Pemphigus Vulgaris
14%
Photochemotherapy
19%
Phototherapy
31%
Psoralen Plus Ultraviolet A
23%
Psoriasis
49%
Psoriatic Patients
14%
Retrospective Analysis
17%
Retrospective Cohort Study
23%
Risk Factors
23%
Rituximab
19%
Serum Levels
19%
Sodium Stibogluconate
35%
Sun Exposure
20%
Sun Protection
19%
Systemic Treatment
19%
Travellers
21%
Treatment Response
14%
Tumor
30%
Ultraviolet-B (UV-B)
100%
Medicine and Dentistry
Adolescent
12%
Amphotericin B
13%
Antibody Response
9%
Atopic Dermatitis
32%
Bullous Pemphigoid
9%
Cutaneous Leishmaniasis
47%
Cutaneous T Cell Lymphoma
11%
Disease
49%
Disease Course
9%
Gene Mutation
9%
Immigrant
9%
Infection
13%
Inflammatory Disorder
12%
Leishmania Major
21%
Leishmania tropica
19%
Lentigo
14%
Lichen Planus
29%
Malignant Neoplasm
12%
Melanocytic Nevus
21%
Mycosis fungoides
69%
Neoplasm
27%
Neural System
9%
Nevus Sebaceous
23%
Nodular Melanoma
74%
Odds Ratio
13%
Pancreas Cancer
12%
Pediatrics
11%
Pemphigus vulgaris
13%
Photochemotherapy
19%
Phototherapy
50%
Pityriasis lichenoides
9%
Prevalence
11%
Psoralen
33%
Psoriasis
41%
PUVA
20%
Quality of Life
11%
Retrospective Cohort Study
22%
Retrospective Study
17%
Rituximab
19%
Side Effect
13%
Skin Cancer
22%
Skin Type
10%
Sodium Stibogluconate
24%
Sun Exposure
17%
Sun Protection
19%
Sunscreen
14%
Systemic Therapy
23%
Torticollis
9%
Treatment Response
11%
Vitiligo
16%